Physiologically-based pharmacokinetics in drug development and regulatory science

M Rowland, C Peck, G Tucker - Annual review of pharmacology …, 2011 - annualreviews.org
The application of physiologically-based pharmacokinetic (PBPK) modeling is coming of
age in drug development and regulation, reflecting significant advances over the past 10 …

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

E Perzborn, S Roehrig, A Straub, D Kubitza… - Nature Reviews Drug …, 2011 - nature.com
The activated serine protease factor Xa is a promising target for new anticoagulants. After
studies on naturally occurring factor Xa inhibitors indicated that such agents could be …

[HTML][HTML] Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development

Y Lai, X Chu, L Di, W Gao, Y Guo, X Liu, C Lu… - … Pharmaceutica Sinica B, 2022 - Elsevier
Drug metabolism and pharmacokinetics (DMPK) is an important branch of pharmaceutical
sciences. The nature of ADME (absorption, distribution, metabolism, excretion) and PK …

The effect of grapefruit juice on drug disposition

MJ Hanley, P Cancalon, WW Widmer… - Expert opinion on drug …, 2011 - Taylor & Francis
Introduction: Since their initial discovery in 1989, grapefruit juice (GFJ)–drug interactions
have received extensive interest from the scientific, medical, regulatory and lay communities …

Medicines, shaken and stirred: a critical review on the ecotoxicology of pharmaceutical mixtures

T Backhaus - … Transactions of the Royal Society B …, 2014 - royalsocietypublishing.org
Analytical monitoring surveys routinely confirm that organisms in the environment are
exposed to complex multi-component pharmaceutical mixtures. We are hence tasked with …

Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model‐based approaches to drug–drug interaction trial design

ML Reitman, X Chu, X Cai, J Yabut… - Clinical …, 2011 - Wiley Online Library
We studied the time course for the reversal of rifampin's effect on the pharmacokinetics of
oral midazolam (a cytochrome P450 (CYP) 3A4 substrate) and digoxin (a P‐glycoprotein (P …

The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so

DB Kell, PD Dobson, E Bilsland, SG Oliver - Drug discovery today, 2013 - Elsevier
A recent paper in this journal sought to counter evidence for the role of transport proteins in
effecting drug uptake into cells, and questions that transporters can recognize drug …

Current issues in patient safety in surgery: a review

FJ Kim, RD da Silva, D Gustafson, L Nogueira… - Patient safety in …, 2015 - Springer
Current surgical safety guidelines and checklists are generic and are not specifically tailored
to address patient issues and risk factors in surgical subspecialties. Patient safety in surgical …

Therapeutic protein–drug interactions and implications for drug development

SM Huang, H Zhao, JI Lee, K Reynolds… - Clinical …, 2010 - Wiley Online Library
Many intrinsic and extrinsic factors can affect an individual patient's drug exposure and
response. 1 The US Food and Drug Administration (FDA) has published a number of …

CYP2A6: genetics, structure, regulation, and function

H Raunio, M Rahnasto-Rilla - Drug metabolism and drug …, 2012 - degruyter.com
The human CYP2A gene subfamily consists of three members, CYP2A6, CYP2A7, and
CYP2A13. The CYP2A6 gene is highly polymorphic with approximately 40 annotated allelic …